Reproductive Toxicity Testing Market - By Product, By Method, By Technology By End-use

Description

List of Tables

Global Reproductive Toxicity Testing Market will witness 9.4% CAGR between 2023 and 2032. The rising emphasis on studies and research and development in the field supports the market. For instance, in June 2023, a groundbreaking study presented at ENDO 2023 introduced a fresh outlook on the reproductive toxicity of phthalates. According to researchers from the University of Illinois Urbana-Champaign, prenatal exposure to these chemicals, commonly used in numerous products, may induce hormonal alterations in females, potentially impacting their future fertility. The study discovered that female mouse embryos exposed to phthalates during gestation exhibited reduced testosterone levels compared to those not exposed to these substances. This research sheds light on phthalates' reproductive toxicity, emphasizing the liver as the principal site of impact.

As awareness of the potential reproductive hazards of chemicals and substances increases, there is a rising need for reliable testing methods. This reproductive toxicity testing market demand is further propelled by stringent regulatory requirements and a commitment to safeguarding public health.

The overall Reproductive Toxicity Testing Market is classified based on product, technology, and region.

Consumables segment will undergo significant development from 2023 to 2032. These essential products, including reagents, assay kits, and laboratory supplies, play a critical role in conducting accurate and reliable reproductive toxicity tests. With an increasing focus on safety assessments and regulatory compliance, industries and research institutions are driving the demand for high-quality consumables in this field. They are essential components in safeguarding human and environmental health, thus justifying their contribution to the reproductive toxicity testing market growth.

High-throughput technology segment will register a noteworthy CAGR from 2023 to 2032. This advanced approach allows for the rapid screening of a large number of compounds for their potential reproductive toxicity, saving time and resources. As regulatory requirements become more stringent and the need for safer products and chemicals increases, high-throughput technology offers a crucial solution to efficiently assess and ensure the safety of various products, driving its contribution to the reproductive toxicity testing market.

Europe reproductive toxicity testing industry will showcase an appreciable CAGR from 2023 to 2032. This growth can be attributed to stringent regulations and a strong emphasis on consumer safety. European authorities require comprehensive assessments of potential reproductive hazards in various industries, including pharmaceuticals, chemicals, and cosmetics. As a result, the demand for reliable reproductive toxicity testing methods and services is on the rise, making it a pivotal component of ensuring public health and environmental protection.

Product Code: 6668

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global reproductive toxicity testing market 360 degree synopsis, 2018 - 2032
2.2 Regional trends
2.3 Product trends
2.4 Method trends
2.5 Technology trends
2.6 End-use trends

Chapter 3 Reproductive Toxicity Testing Industry Insights

3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
- 3.5.1 Growth drivers
  - 3.5.1.1 Increasing demand for reproductive toxicology testing products
  - 3.5.1.2 Increasing drug development and discovery
  - 3.5.1.3 Rising usage of pharmacogenomics
  - 3.5.1.4 Advancements in testing methods
- 3.5.2 Industry pitfalls & challenges
  - 3.5.2.1 Dearth skilled professionals
  - 3.5.2.2 High cost associated with reproductive toxicology testing and products
3.6 Growth potential analysis
- 3.6.1 By product
- 3.6.2 By method
- 3.6.3 By technology
- 3.6.4 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
- 4.1.1 Thermo Fisher Scientific, Inc.
- 4.1.2 Charles River Laboratories International
- 4.1.3 Eurofins Scientific
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022

Chapter 5 Reproductive Toxicity Testing Market Estimates and Forecast, By Product (Revenue)

5.1 Key trends, by product
5.2 Consumables
5.3 Assays
- 5.3.1 Bacterial toxicity assays
- 5.3.2 Enzyme toxicity assays
- 5.3.3 Cell-based elisa & western blot
- 5.3.4 Receptor-binding assays
- 5.3.5 Tissue culture assays
- 5.3.6 Other assays
5.4 Equipment
5.5 Others

Chapter 6 Reproductive Toxicity Testing Market Estimates and Forecast, By Method (Revenue)

6.1 Key trends, by method
6.2 Cellular assays
6.3 Biochemical assays
6.4 In-silico models
6.5 Ex-vivo models

Chapter 7 Reproductive Toxicity Testing Market Estimates and Forecast, By Technology (Revenue)

7.1 Key trends, by technology
7.2 Cell culture technology
7.3 High-throughput technology
7.4 Toxicogenomics

Chapter 8 Reproductive Toxicity Testing Market Estimates and Forecast, By End-use (Revenue)

8.1 Key trends, by end-use
8.2 Academic and research institutes
8.3 Pharmaceutical and biotechnology companies
8.4 Contract research organizations
8.5 Others

Chapter 9 Reproductive Toxicity Testing Market Estimates and Forecast, By Region (Revenue)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Switzerland
- 9.3.7 The Netherlands
- 9.3.8 Denmark
- 9.3.9 Poland
- 9.3.10 Sweden
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 New Zealand
- 9.4.7 Thailand
- 9.4.8 Vietnam
- 9.4.9 Indonesia
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Colombia
- 9.5.5 Chile
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Turkey

Chapter 10 Company Profiles

10.1 Thermo Fisher Scientific, Inc.
10.2 Charles River Laboratories International
10.3 Laboratory Corporation of America Holdings
10.4 Eurofins Scientific
10.5 Jubilant Life Sciences Limited
10.6 Syngene International Limited
10.7 Gentronix Ltd.
10.8 Inotiv Inc.
10.9 Creative Bioarray
10.10 MB Research Laboratories
10.11 Bio-Rad Laboratories, Inc.
10.12 Catalent, Inc.
10.13 Evotec
10.14 QIAGEN
10.15 Promega Corporation